Biopharma Group Articles & Resources

August 18, 2022

Staff Spotlight – Dr Kevin Ward

At Biopharma Group we are aiming to highlight the incredible team we have and shine light on the key areas of there roles. Our latest staff spotlight is on our Director of Research & Development; Doctor Kevin Ward. We sat down with him to under stand his role in more detail and other interesting facts about him.
August 17, 2022

Vapour Pressure of Ice

The driving force behind freeze drying is the pressure differential between the product chamber and the condenser: the greater the difference, the faster the flow of vapour away from the drying product. The condenser must be significantly colder than the product for effective freeze drying. The table below shows the pressures/temperatures at which ice will sublime directly into a gas.
August 17, 2022

Scientific Poster: Quantification of the Physical Robustness of Lyophilized Biotherapeutics

Download the Scientific Poster
August 17, 2022

Application Note: Investigating the Effect of Glycerol on the Mechanical Properties of Model Biotherapeutic Formulations

Download Application Note
August 17, 2022

Application note DSC Analysis of formulations for Freeze Drying

Download Application Note
August 17, 2022

Optimisation of Lyophilisation Process Development in the Biopharmaceutical Industry
An 
Application of the Lyotherm3 Frozen State Solution Analyser

Download Application Note
August 17, 2022

Application note: Process Analytical Technology employed in the Freeze Drying Process to determine the End of Primary drying and Cycle Optimisation

Process Analytical Technologies (PAT) are analytical methods that can help to monitor a process in real time, enabling measurement of its effectiveness and assess how well the process achieves its end goal.
August 17, 2022

Application TechNote: PCR Diagnostic Kits & Freeze-Drying Considerations

Read the latest TechNote from SP Scientific:
August 12, 2022

How & why to build a QbD process to optimise the efficiency of your freeze drying projects

Quality by design (QbD) for lyophilisation is about building a robust process that proactively flags critical points and ensures consistent delivery of the best quality product, not only by minimising risk but also through greater understanding of the process itself. Regulatory bodies such as the FDA require details of the lyophilisation cycle